A common canine presentation in vet practice, many skin diseases can cause pruritus, and differentials include infection, ectoparasites and hypersensitivity – increasingly to food. Discussing some of this, RCVS and European Board of Veterinary Specialisation-recognised specialist in veterinary dermatology Carly Mason joins this Vet Times Podcast. _________________________________ 𝗖𝗔𝗥𝗟𝗬 𝗠𝗔𝗦𝗢𝗡 𝗕𝗩𝗦𝗰, 𝗖𝗲𝗿𝘁𝗩𝗗, 𝗗𝗶𝗽𝗘𝗖𝗩𝗗, 𝗠𝗥𝗖𝗩𝗦 Carly graduated from the University of Bristol Veterinary School in 2003. She spent seven years in general practice before completing a European College of Veterinary Dermatology (ECVD) veterinary dermatology residency at Rutland House Referrals in 2014. Carly achieved an ECVD Veterinary Dermatology Diploma in 2014 and is an RCVS and European-recognised specialist in veterinary dermatology. She works as a UKVetDerm veterinary dermatology consultant in the south-east for Guide Dogs and three private referral centres (Chiltern Referral Services, Pennard Vets and Veterinary Referral Centre). Carly is also an assessor and examiner for the University of Liverpool postgraduate CertAVP in Dermatology qualification. She enjoys all aspects of being a veterinary dermatologist and has a particular interest in autoimmune skin diseases, allergic skin disease and otitis. She wrote an article in Vet Times (Volume 53, Issue 7, Pages 4-8) called “Working up pruritic dogs – practical tips for diet trials”. This content is now online as part of our CPD+ Dermatology collection at www.vettimes.co.uk/article/working-up-pruritic-dogs-practical-tips-for-diet-trials-cpddermatology/ _________________________________ 𝗦𝗣𝗢𝗡𝗦𝗢𝗥𝗘𝗗 This podcast is sponsored by Zoetis, makers of Apoquel Chewable. Apoquel Chewable provides the same benefits as original Apoquel, in a treat-like formulation¹. The highly palatable tablets offer fast, effective relief from canine allergic dermatitis, in a convenient, pet-friendly form²,³ . For more information on Apoquel Chewable, speak to your Zoetis Account Manager or visit www2.zoetis.co.uk/apoquelchewable 𝖱𝖾𝖿𝖾𝗋𝖾𝗇𝖼𝖾𝗌 1. Apoquel Chewable SPC. 2. Visser M et al (2022). Acceptance of oclacitinib maleate (Apoquel) chewable tablets in client-owned dogs with allergic and atopic dermatitis, BMC Vet Res 18: 103. 3. Fleck T et al (2022). Speed of onset of a new chewable formulation of oclacitinib maleate (Apoquel) in a canine model of IL-31-induced pruritus, J Vet Pharmacol Ther 45(4): 380-384.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related